Slc15a2-flox 基因敲除小鼠

1. Yin, Wenjun, He, Pingkaiqi, Zou, Zhihao, Lu, Jianming, Zhong, Weide. 2024. SLC15A2 Serves as a Novel Prognostic Biomarker and Target for Prostate Cancer. In Anticancer research, 45, 153-172. doi:10.21873/anticanres.17402. https://pubmed.ncbi.nlm.nih.gov/39740843/

2. Ji, Juanjuan, Li, Xudong, Zhu, Yaling, Peng, Bei, Zhou, Zhi. . Screening of periodontitis-related diagnostic biomarkers based on weighted gene correlation network analysis and machine algorithms. In Technology and health care : official journal of the European Society for Engineering and Medicine, 30, 1209-1221. doi:10.3233/THC-THC213662. https://pubmed.ncbi.nlm.nih.gov/35342071/

3. Cai, Liang-Liang, Huang, Wen-Qing, Su, Zhi-Ying, Zhang, Wei, Tzeng, Chi-Meng. 2017. Identification of two novel genes SLC15A2 and SLCO1B3 associated with maintenance dose variability of warfarin in a Chinese population. In Scientific reports, 7, 17379. doi:10.1038/s41598-017-17731-1. https://pubmed.ncbi.nlm.nih.gov/29234073/

4. Lee, Yeon-Su, Kim, Bo Hyun, Kim, Byung Chul, Bhak, Jong, Park, Joong-Won. . SLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: whole-genome analysis in patients with hepatocellular carcinoma. In Oncotarget, 6, 16449-60. doi:. https://pubmed.ncbi.nlm.nih.gov/25965825/